[ad_1]
The administration of Donald trump turned down an offer by pharmaceutical company Pfizer to buy additional doses of the vaccine of coronavirus it develops, so it may not generate enough for the United States until June 2021.
As reported by the newspaper The New York Times, sources close to the White House indicated that a few months ago the deal with Pfizer was rejected amid the compromise that Trump seeks through an executive order to “ensure that the US Government gives priority to making vaccines reach the citizens before sending them to other nations. “
Meanwhile, it is unknown what Trump’s order consists of and whether it would lead to expanding the number of doses contained in existing federal contracts.
Pfizer, for its part, warned that it may not generate enough vaccines for the country until June 2021 given the commitment it made to other countries.
The Pfizer vaccine, which it has developed together with the German BioNTech, is a two-dose treatment, so the 100 million doses that the US would have bought would serve to inoculate only 50 million people.
This vaccine is expected to be authorized this weekend by the US authorities, while the United Kingdom already began to inoculate the population on Tuesday, being the first country to begin mass vaccinations.
For his part, a senior official denied that Pfizer offered a greater number of vaccines and noted that “that is false. We are in the middle of negotiations right now, but we are going to have all the doses to vaccinate Americans who want it by the end of the second quarter of 2021, “he said.
